bathocuproine disulfonate has been researched along with Leukemia L 1210 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fisher, JM; Rabinovitz, M | 1 |
| Fisher, JM; Mohindru, A; Rabinovitz, M | 1 |
| Bannai, S; Ishii, T | 1 |
3 other study(ies) available for bathocuproine disulfonate and Leukemia L 1210
| Article | Year |
|---|---|
Protection against cytotoxicity of endogenous copper in the requirement for mercaptoethanol by a lymphoma in primary culture.
Topics: Animals; Cell Division; Cell Line; Cell Survival; Chelating Agents; Copper; Leukemia L1210; Lymphoma; Mercaptoethanol; Mice; Phenanthrolines | 1982 |
Endogenous copper is cytotoxic to a lymphoma in primary culture which requires thiols for growth.
Topics: Animals; Cell Division; Chelating Agents; Copper; Cysteine; Leukemia L1210; Mice; Oxidation-Reduction; Phenanthrolines; Sulfhydryl Compounds | 1985 |
The synergistic action of the copper chelator bathocuproine sulphonate and cysteine in enhancing growth of L1210 cells in vitro.
Topics: Animals; Blood; Cell Count; Cell Division; Cysteine; Drug Synergism; Leukemia L1210; Mercaptoethanol; Mice; Phenanthrolines; Sulfhydryl Compounds | 1985 |